Akt enhances Mdm2-mediated ubiquitination and degradation of p53.

The Journal of Biological Chemistry
Yoko OgawaraY Gotoh

Abstract

p53 plays a key role in DNA damage-induced apoptosis. Recent studies have reported that the phosphatidylinositol 3-OH-kinase-Akt pathway inhibits p53-mediated transcription and apoptosis, although the underlying mechanisms have yet to be determined. Mdm2, a ubiquitin ligase for p53, plays a central role in regulation of the stability of p53 and serves as a good substrate for Akt. In this study, we find that expression of Akt reduces the protein levels of p53, at least in part by enhancing the degradation of p53. Both Akt expression and serum treatment induced phosphorylation of Mdm2 at Ser186. Akt-mediated phosphorylation of Mdm2 at Ser186 had little effect on the subcellular localization of Mdm2. However, both Akt expression and serum treatment increased Mdm2 ubiquitination of p53. The serum-induced increase in p53 ubiquitination was blocked by LY294002, a phosphatidylinositol 3-OH-kinase inhibitor. Moreover, when Ser186 was replaced by Ala, Mdm2 became resistant to Akt enhancement of p53 ubiquitination and degradation. Collectively, these results suggest that Akt enhances the ubiquitination-promoting function of Mdm2 by phosphorylation of Ser186, which results in reduction of p53 protein. This study may shed light on the mech...Continue Reading

References

May 8, 1992·Science·S E KernB Vogelstein
May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·P F JonesB A Hemmings
Jul 1, 1993·Molecular and Cellular Biology·J ChenA J Levine
May 15, 1997·Nature·Y HauptM Oren
May 15, 1997·Nature·M H KubbutatK H Vousden
Aug 1, 1997·Genes & Development·C J ThutR Tjian
Aug 1, 1998·The Journal of Biological Chemistry·M Pap, G M Cooper
Sep 23, 1998·Nature·I PalmeroM Serrano
Oct 9, 1998·Genes & Development·C J Sherr
Nov 13, 1998·Science·M H CardoneJ C Reed
Nov 21, 1998·Oncogene·S Y FuchsZ Ronai
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·W Tao, A J Levine
Sep 15, 1999·Nature·J A Romashkova, S S Makarov
Nov 13, 1999·Nature Cell Biology·J D WeberD Bar-Sagi
Dec 2, 1999·Genes & Development·S R DattaM E Greenberg
Aug 18, 2000·The Journal of Biological Chemistry·T ObataL C Cantley
Sep 12, 2000·Nature Cell Biology·S D BoydT Jacks
Sep 12, 2000·Nature Cell Biology·R K GeyerC G Maki
Sep 13, 2000·Molecular Cell·J LaineM Noguchi
Oct 31, 2000·The Journal of Biological Chemistry·A YamaguchiM Tohyama
Nov 4, 2000·The Journal of Cell Biology·H ZhouR N Pittman
Nov 9, 2000·Proceedings of the National Academy of Sciences of the United States of America·E KobetH Lu
Dec 15, 2000·Cell·K H Vousden
Mar 10, 2001·Experimental Cell Research·D B Woods, K H Vousden

❮ Previous
Next ❯

Citations

Oct 25, 2011·European Journal of Nutrition·Andzelika BorkowskaJedrzej Antosiewicz
May 3, 2005·Journal of Cancer Research and Clinical Oncology·Wolfgang J KöstlerChristoph C Zielinski
Nov 15, 2011·Breast Cancer Research and Treatment·Jin Cheon KimDong-Hyung Cho
Mar 17, 2004·Biochimica Et Biophysica Acta·Masahito HanadaBrian A Hemmings
May 9, 2013·Brain Research Bulletin·Minjae LeeSung-Wuk Jang
Aug 24, 2013·Differentiation; Research in Biological Diversity·Luís Marques, Sólveig Thorsteinsdóttir
Jan 28, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Aurora O'Brate, Paraskevi Giannakakou
Oct 1, 2013·Expert Reviews in Molecular Medicine·R KosterS de Jong
Oct 29, 2008·Oncogene·T F Franke
Oct 26, 2005·Oncogene·C SegrellesJ M Paramio
Mar 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yoshinori AbeNobuyuki Tanaka
Feb 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Mohit SachdevaYin-Yuan Mo
Aug 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Hyo-Jin KimYong-Keun Jung
Jul 17, 2009·The Journal of Biological Chemistry·Theodore W Small, J Geoffrey Pickering
Feb 16, 2012·The Journal of Biological Chemistry·Sungman ParkJin Q Cheng
Mar 22, 2008·The Journal of Biological Chemistry·Vanessa Lopez-PajaresZhi-Min Yuan
Feb 22, 2012·Stem Cells and Development·Jared M CampbellMichelle Lane
May 11, 2010·Cold Spring Harbor Perspectives in Biology·Xin Lu
Jul 28, 2006·Cold Spring Harbor Symposia on Quantitative Biology·S L HarrisA J Levine
May 17, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·P AthanassiadouE Patsouris
Feb 27, 2008·Acta Pharmacologica Sinica·Rong-gang XiLi-jun Wu
Dec 7, 2005·The Journal of Pharmacology and Experimental Therapeutics·Yun-Sik LeeByoung J Song
Sep 20, 2006·Molecular and Cellular Biology·Kirsten H LimesandSteven M Anderson
Feb 24, 2004·Annual Review of Physiology·Mark A Sussman, Piero Anversa
Apr 16, 2010·American Journal of Physiology. Renal Physiology·Benjamin KoRobert S Hoover
Jul 12, 2011·Physiological Reviews·Mark A SussmanMichael McGregor
Oct 21, 2011·Dermatology Research and Practice·Ichiro YajimaMasashi Kato

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.